Issue 5, 2014

Evaluation of changes in monoamine levels and apoptosis induced by cyfluthrin in rats

Abstract

The aim of this study was to evaluate monoamine and mitochondrial cytochrome c levels and lipid peroxidation in adult male rats treated with cyfluthrin (14 mg kg−1 dose; approximately 1/10 of the LD50 value) for 14 days. This study also examined cyfluthrin induced apoptosis via the signaling proteins Bcl-2, caspase-9 and caspase-3, and possible anti-apoptotic effects of alpha-basic crystallin (αB-c). Levels of epinephrine (E), norepinephrine (NE) and serotonin (5-hydroxytryptamine, 5-HT) in the plasma and 5-HT and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) were measured in the striatum to assess neurotransmitter modification. Cyfluthrin administered to the plasma significantly reduced the levels of E and NE and increased 5-HT levels, with no significant increase in lipid peroxidation. In the striatum, cyfluthrin intoxication resulted in a significant increase of the level of 5-HIAA but no significant increase in 5-HT. Apoptosis was detected in astrocytes without a change in the level of cytochrome c but was not detected in neurons. Immunohistochemically caspase-9 positive and Bcl-2 negative neurons were identified. Although these neurons were also negative for both TUNEL staining and caspase-3, they were positive for αB-c. The present study may indicate that cyfluthrin toxicity appears first in neuronal supportive cells, especially astrocytes, rather than in neurons, and that in neurons, αB-c can inhibit the activation of caspase-3 and block apoptosis. In conclusion, our findings support the hypothesis that repeated exposure to cyfluthrin alters neurotransmission of E, NE and 5-HT and induces apoptosis. These data may therefore be important for assessing the safety of cyfluthrin.

Graphical abstract: Evaluation of changes in monoamine levels and apoptosis induced by cyfluthrin in rats

Article information

Article type
Paper
Submitted
06 May 2014
Accepted
03 Jun 2014
First published
04 Jun 2014

Toxicol. Res., 2014,3, 331-340

Author version available

Spotlight

Advertisements